Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-14-026482
Filing Date
2014-04-08
Accepted
2014-04-08 17:30:16
Documents
5
Effectiveness Date
2014-04-08

Document Format Files

Seq Description Document Type Size
1 DEFA14A a14-2302_3defa14a.htm DEFA14A 8417
2 GRAPHIC g23023bci001.gif GRAPHIC 54515
3 GRAPHIC g23023bci002.gif GRAPHIC 79906
4 GRAPHIC g23023bci003.gif GRAPHIC 19801
5 GRAPHIC g23023bci004.gif GRAPHIC 3871
  Complete submission text file 0001104659-14-026482.txt   227800
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-29889 | Film No.: 14751959
SIC: 2834 Pharmaceutical Preparations